These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9605006

  • 21. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
    Mlcáková A, Babusíková O.
    Neoplasma; 2003; 50(6):416-21. PubMed ID: 14689062
    [Abstract] [Full Text] [Related]

  • 22. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M, Babusíková O.
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [Abstract] [Full Text] [Related]

  • 23. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides.
    Rani S, De Oliveira MS, Catovsky D.
    Hematol Pathol; 1988; 2(2):73-8. PubMed ID: 2974027
    [Abstract] [Full Text] [Related]

  • 24. Analysis of CD1 molecules on haematological malignancies of myeloid and lymphoid origin. I. Cell surface antigen expression.
    Salamone MC, Roisman FR, Santiago J, Satz ML, Fainboim L.
    Dis Markers; 1990; 8(5):265-74. PubMed ID: 1707769
    [Abstract] [Full Text] [Related]

  • 25. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 26. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M, Koníková E, Stasáková J, Babusíková O.
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [Abstract] [Full Text] [Related]

  • 27. Detection of cytoplasmic and surface membrane markers in cells of some human hematopoietic cell lines.
    Koníková E, Babusíková O, Kusenda J, Glasová M.
    Neoplasma; 1992; 39(6):337-42. PubMed ID: 1491722
    [Abstract] [Full Text] [Related]

  • 28. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 29. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.
    Lavabre-Bertrand T, Duperray C, Brunet C, Poncelet P, Exbrayat C, Bourquard P, Lavabre-Bertrand C, Brochier J, Navarro M, Janossy G.
    Leukemia; 1994 Mar; 8(3):402-8. PubMed ID: 8127145
    [Abstract] [Full Text] [Related]

  • 30. A quantitative exploration of surface antigen expression in common B-cell malignancies using flow cytometry.
    Olejniczak SH, Stewart CC, Donohue K, Czuczman MS.
    Immunol Invest; 2006 Mar; 35(1):93-114. PubMed ID: 16531332
    [Abstract] [Full Text] [Related]

  • 31. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G, Schmitz G.
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [Abstract] [Full Text] [Related]

  • 32. [Immunophenotyping of leukemia: overview].
    Huber K, Worofka B, Kittl E, Tomasits J, Hofmann J, Bauer K.
    Wien Klin Wochenschr; 1994 May; 106(8):226-30. PubMed ID: 8023514
    [Abstract] [Full Text] [Related]

  • 33. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
    Babusíková O, Glasová M, Kusenda J, Koníková E, Mésárosová A.
    Neoplasma; 1994 May; 41(6):305-13. PubMed ID: 7870213
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression.
    Lavabre-Bertrand T, Janossy G, Ivory K, Peters R, Secker-Walker L, Porwit-MacDonald A.
    Cytometry; 1994 Dec 15; 18(4):209-17. PubMed ID: 7895527
    [Abstract] [Full Text] [Related]

  • 36. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E, Tani E, Björklund E, Elmberger G, Everaus H, Skoog L, Porwit-MacDonald A.
    Cytometry B Clin Cytom; 2005 Mar 15; 64(1):34-42. PubMed ID: 15669024
    [Abstract] [Full Text] [Related]

  • 37. The interaction and functional properties of leukocyte molecules of human leukemia/lymphoma cells.
    Koubek K, Babusíková O.
    Sb Lek; 2003 Mar 15; 104(2):183-97. PubMed ID: 14577128
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The relationship between argyrophilic proteins and some immunophenotypic markers in acute leukemia cells.
    Klobusická M, Babusíková O.
    Neoplasma; 1997 Mar 15; 44(6):356-60. PubMed ID: 9605007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.